The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...
This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...
Under the agreement, PharmAla will provide its LaNeo™ MDMA at no charge to Spaulding Rehabilitation for use in a study entitled “Hyperscan Neuroimaging to Reveal the Brain Mechanisms Supporting ...
A Senate committee approved a bill expanding medical marijuana eligibility on Tuesday and voted down another allowing it in ...
If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with ...
TEL AVIV, Israel (AP) — Israel’s top court on Friday moved to allow international aid groups to keep operating in the Gaza ...
Dosing of Cohort 1 complete with first three patients having received starting dose of JAG201 delivered via ...
Findings presented at the 2026 ASCO GU Symposium show that combinatorial therapies may provide new treatment options for patients with renal cell carcinoma or muscle-invasive bladder cancer.
HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer ...
STORY SUMMARYFlorida data center restrictions advance in House committeeA Florida House committee approved a bill that would ...
The World Trade Center's final office tower will start construction as soon as this spring and become American Express ' new headquarters, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results